Literature DB >> 3665680

Persistence of Campylobacter pyloridis despite healing of duodenal ulcer and improvement of accompanying duodenitis and gastritis.

W M Hui1, S K Lam, P Y Chau, J Ho, I Lui, C L Lai, A S Lok, M M Ng.   

Abstract

Campylobacter pyloridis has been associated with antral gastritis and duodenal ulcer. To study the pathogenetic role of these organisms in duodenal ulcer, endoscopic biopsies, two from the first part of duodenum, four from antrum, and four from body and fundus, were taken before and after four weeks of cimetidine treatment (1.2 g/day) from 67 patients with active duodenal ulcer. The biopsies were examined for the presence and severity of any inflammation by two independent pathologists in the absence of any clinical information and for the occurrence and density of Campylobacter pyloridis by culture and Warthin-Starry stain. Before treatment, inflammation was present in 71.1, 100, and 25.8%, while the organisms were present in 34.3, 91.0, and 79.1% of the duodenal, antral, and fundal biopsies, respectively. With complete healing of duodenal ulcer, inflammation was present in 48.9, 98.2, and 30.2%, while the organisms were present in 25, 76.7, and 63.3% of the respective mucosae. With ulcer healing, duodenitis became significantly milder (P less than 0.05). With improvement of gastritis and duodenitis, there was no significant change in the occurrence and density of Campylobacter pyloridis. These findings indicate that healing of duodenal ulcer is not influenced by the presence of Campylobacter pyloridis, which is frequently found in the gastroduodenal mucosa of patients with duodenal ulcer, but does not appear to be associated with mucosal inflammation except in the antrum.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3665680     DOI: 10.1007/bf01296375

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  13 in total

1.  Chronic antral gastritis in duodenal ulcer. Natural history and treatment with prostaglandin E1.

Authors:  W M Hui; S K Lam; J Ho; M M Ng; I Lui; C L Lai; A S Lok; W Y Lau; G P Poon; S Choi
Journal:  Gastroenterology       Date:  1986-11       Impact factor: 22.682

2.  Pyloric campylobacter serology.

Authors:  B J Marshall; D B McGechie; G J Francis; P J Utley
Journal:  Lancet       Date:  1984-08-04       Impact factor: 79.321

3.  Unidentified curved bacilli on gastric epithelium in active chronic gastritis.

Authors:  J R Warren; B Marshall
Journal:  Lancet       Date:  1983-06-04       Impact factor: 79.321

4.  Immune response to Campylobacter pyloridis in patients with peptic ulceration.

Authors:  J Kaldor; W Tee; P McCarthy; J Watson; B Dwyer
Journal:  Lancet       Date:  1985-04-20       Impact factor: 79.321

5.  Spiral organisms in endoscopic biopsies of the human stomach.

Authors:  T P Rollason; J Stone; J M Rhodes
Journal:  J Clin Pathol       Date:  1984-01       Impact factor: 3.411

6.  Campylobacter pyloridis in peptic ulcer disease: microbiology, pathology, and scanning electron microscopy.

Authors:  A B Price; J Levi; J M Dolby; P L Dunscombe; A Smith; J Clark; M L Stephenson
Journal:  Gut       Date:  1985-11       Impact factor: 23.059

7.  Sucralfate overcomes adverse effect of cigarette smoking on duodenal ulcer healing and prolongs subsequent remission.

Authors:  S K Lam; W M Hui; W Y Lau; F J Branicki; C L Lai; A S Lok; M M Ng; P J Fok; G P Poon; T K Choi
Journal:  Gastroenterology       Date:  1987-05       Impact factor: 22.682

8.  Pyloric Campylobacter infection and gastroduodenal disease.

Authors:  B J Marshall; D B McGechie; P A Rogers; R J Glancy
Journal:  Med J Aust       Date:  1985-04-15       Impact factor: 7.738

9.  Accurate prediction of duodenal-ulcer healing rate by discriminant analysis.

Authors:  S K Lam; J Koo
Journal:  Gastroenterology       Date:  1983-08       Impact factor: 22.682

10.  Relapse rates after initial ulcer healing with sucralfate and cimetidine.

Authors:  I N Marks; J P Wright; W Lucke; A H Girdwood
Journal:  Scand J Gastroenterol       Date:  1982-04       Impact factor: 2.423

View more
  18 in total

Review 1.  Helicobacter pylori in gastroduodenal disease.

Authors:  R J Loffeld
Journal:  Pharm Weekbl Sci       Date:  1990-04-27

Review 2.  Campylobacter pylori and gastroduodenal disease.

Authors:  G E Buck
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

3.  H. pylori-negative duodenal ulcer prevalence and causes in 774 patients.

Authors:  J P Gisbert; M Blanco; J M Mateos; L Fernández-Salazar; M Fernández-Bermejo; J Cantero; J M Pajares
Journal:  Dig Dis Sci       Date:  1999-11       Impact factor: 3.199

4.  Inappropriate hypergastrinaemia in asymptomatic healthy subjects infected with Helicobacter pylori.

Authors:  J T Smith; R E Pounder; C U Nwokolo; S Lanzon-Miller; D G Evans; D Y Graham; D J Evans
Journal:  Gut       Date:  1990-05       Impact factor: 23.059

Review 5.  Helicobacter pylori and peptic ulcer disease.

Authors:  M Feldman; W L Peterson
Journal:  West J Med       Date:  1993-11

6.  Treatment of Helicobacter pylori-associated gastroduodenal disease in children. Clinical evaluation of antisecretory vs antibacterial therapy.

Authors:  C Rosioru; M S Glassman; S H Berezin; H E Bostwick; M Halata; S M Schwarz
Journal:  Dig Dis Sci       Date:  1993-01       Impact factor: 3.199

7.  Role of Helicobacter pylori in cirrhotic patients with peptic ulcer. A serological study.

Authors:  J J Chen; C S Changchien; D I Tai; S S Chiou; C M Lee; C H Kuo
Journal:  Dig Dis Sci       Date:  1994-07       Impact factor: 3.199

8.  Duodenal ulcer, Helicobacter pylori, and gastric secretion.

Authors:  K Chandrakumaran; D Vaira; M Hobsley
Journal:  Gut       Date:  1994-08       Impact factor: 23.059

9.  Effect of Helicobacter pylori infection on 24 hour intragastric acidity in patients with gastritis and duodenal ulcer.

Authors:  S Wagner; U Gladziwa; K Haruma; M Varrentrapp; M Gebel
Journal:  Gut       Date:  1992-08       Impact factor: 23.059

10.  Helicobacter pylori and gastric acid output in peptic ulcer disease.

Authors:  J Y Kang; A Wee
Journal:  Dig Dis Sci       Date:  1991-01       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.